Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.
Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, Reeder PJ, Momin MM, Bergeron CG, Guilmain SE, Miller PF, Kurtz CB, Falb D.
Isabella VM, et al. Among authors: fisher ab.
Nat Biotechnol. 2018 Oct;36(9):857-864. doi: 10.1038/nbt.4222. Epub 2018 Aug 13.
Nat Biotechnol. 2018.
PMID: 30102294